This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Diamedica Inc.. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2017
Title: Tadeusz Kolodka: Innovator in Human Tissue Research
Introduction
Tadeusz Kolodka is a notable inventor based in Plymouth, MN (US). He has made significant contributions to the field of human tissue research, particularly in the area of glycosylation isoforms of tissue kallikrein-1. With a total of 2 patents, his work has implications for therapeutic applications.
Latest Patents
Kolodka's latest patents focus on the preparations of tissue kallikrein-1 (KLK1) glycoforms. These patents provide detailed methodologies for obtaining KLK1 glycoforms that have a defined number of oligosaccharide units per KLK1 molecule. Additionally, they include pharmaceutical compositions containing these glycoforms, as well as methods for their therapeutic uses.
Career Highlights
Tadeusz Kolodka is currently associated with Diamedica Inc., where he continues to advance his research in human tissue kallikrein. His innovative work has positioned him as a key figure in the development of new therapeutic strategies.
Collaborations
Kolodka collaborates with notable colleagues, including Matthew Charles and Mark F Williams. Their combined expertise enhances the research and development efforts at Diamedica Inc.
Conclusion
Tadeusz Kolodka's contributions to the field of human tissue research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile